dasiglucagon hydrochloride · Zealand Pharma · NDA 214231
Zegalogue
Earliest generic entry, as listed
22 Mar 2035
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10442847.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10442847 | drug substance, drug product · sets the listed date | 22 Mar 2035 |
| US 11795204 | use U-3752 | 6 Jan 2034 |
Exclusivities · 1 unexpired
| NPP | new patient population | 18 Jun 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214231 · 001 · RLD · discontinued | solution, subcutaneous | EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML) | 22 Mar 2035 |
Expired or delisted (1)
- NCE · 22 Mar 2026